Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-κB pathways

Yau Chong Chang, Pei Chih Li, Bing Chang Chen, Ming Shyan Chang, Jui Ling Wang, Wen Ta Chiu, Chien Huang Lin

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

We recently reported that lipoteichoic acid (LTA), a cell wall component of the gram-positive bacterium Staphylococcus aureus, stimulated inducible nitric oxide synthase (iNOS) expression, nitric oxide (NO) release, and cyclooxygenase-2 (COX-2) expression in RAW 264.7 macrophages. This study was carried out to further investigate the roles of COX-2 and prostaglandin E2 (PGE2) in LTA-induced iNOS expression and NO release in RAW 264.7 macrophages. Treatment of RAW 264.7 macrophages with LTA caused a time-dependent increase in PGE2 release. LTA-induced iNOS expression and NO release were inhibited by a non-selective COX inhibitor (indomethacin), a selective COX-2 inhibitor (NS-398), an adenylyl cyclase (AC) inhibitor (dideoxyadenosine, DDA), and a protein kinase A (PKA) inhibitor (KT-5720). Furthermore, both PGE2 and the direct PKA activator, dibutyryl-cAMP, also induced iNOS expression in a concentration-dependent manner. Stimulation of RAW 264.7 macrophages with LTA, PGE2, and dibutyryl-cAMP all caused p38 MAPK activation in a time-dependent manner. LTA-mediated p38 MAPK activation was inhibited by indomethacin, NS-398, and SB 203580, but not by PD 98059. The PGE2-mediated p38 MAPK activation was inhibited by DDA, KT-5720, and SB 203580, but not by PD 98059. LTA caused time-dependent activation of the nuclear factor-κB (NF-κB)-specific DNA-protein complex formation. The LTA-induced increase in κB-luciferase activity was inhibited by indomethacin, NS-398, KT-5720, and a dominant negative mutant of p38 αMAPK (p38 αMAPK DN). These results suggest that LTA-induced iNOS expression and NO release involve COX-2-generated PGE2 production, and AC, PKA, p38 MAPK, and NF-κB activation in RAW 264.7 macrophages.

Original languageEnglish
Pages (from-to)1235-1243
Number of pages9
JournalCellular Signalling
Volume18
Issue number8
DOIs
Publication statusPublished - Aug 2006
Externally publishedYes

Fingerprint

p38 Mitogen-Activated Protein Kinases
Cyclooxygenase 2
Cyclic AMP-Dependent Protein Kinases
Dinoprostone
Nitric Oxide Synthase
Macrophages
Nitric Oxide Synthase Type II
Nitric Oxide
Dideoxyadenosine
Indomethacin
lipoteichoic acid
Cyclooxygenase 2 Inhibitors
Gram-Positive Bacteria
Cellular Structures
Protein Kinase Inhibitors
Luciferases
Adenylyl Cyclases
Cell Wall
Staphylococcus aureus
DNA

Keywords

  • Cyclooxygenase-2
  • Inducible nitric oxide synthase
  • Lipoteichoic acid
  • Nitric oxide
  • Nuclear factor-κB
  • Prostaglandin E
  • Protein kinase A
  • RAW 264.7 macrophages

ASJC Scopus subject areas

  • Cell Biology

Cite this

Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-κB pathways. / Chang, Yau Chong; Li, Pei Chih; Chen, Bing Chang; Chang, Ming Shyan; Wang, Jui Ling; Chiu, Wen Ta; Lin, Chien Huang.

In: Cellular Signalling, Vol. 18, No. 8, 08.2006, p. 1235-1243.

Research output: Contribution to journalArticle

@article{5ae9e7b444af451982989fbd9c7729c1,
title = "Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-κB pathways",
abstract = "We recently reported that lipoteichoic acid (LTA), a cell wall component of the gram-positive bacterium Staphylococcus aureus, stimulated inducible nitric oxide synthase (iNOS) expression, nitric oxide (NO) release, and cyclooxygenase-2 (COX-2) expression in RAW 264.7 macrophages. This study was carried out to further investigate the roles of COX-2 and prostaglandin E2 (PGE2) in LTA-induced iNOS expression and NO release in RAW 264.7 macrophages. Treatment of RAW 264.7 macrophages with LTA caused a time-dependent increase in PGE2 release. LTA-induced iNOS expression and NO release were inhibited by a non-selective COX inhibitor (indomethacin), a selective COX-2 inhibitor (NS-398), an adenylyl cyclase (AC) inhibitor (dideoxyadenosine, DDA), and a protein kinase A (PKA) inhibitor (KT-5720). Furthermore, both PGE2 and the direct PKA activator, dibutyryl-cAMP, also induced iNOS expression in a concentration-dependent manner. Stimulation of RAW 264.7 macrophages with LTA, PGE2, and dibutyryl-cAMP all caused p38 MAPK activation in a time-dependent manner. LTA-mediated p38 MAPK activation was inhibited by indomethacin, NS-398, and SB 203580, but not by PD 98059. The PGE2-mediated p38 MAPK activation was inhibited by DDA, KT-5720, and SB 203580, but not by PD 98059. LTA caused time-dependent activation of the nuclear factor-κB (NF-κB)-specific DNA-protein complex formation. The LTA-induced increase in κB-luciferase activity was inhibited by indomethacin, NS-398, KT-5720, and a dominant negative mutant of p38 αMAPK (p38 αMAPK DN). These results suggest that LTA-induced iNOS expression and NO release involve COX-2-generated PGE2 production, and AC, PKA, p38 MAPK, and NF-κB activation in RAW 264.7 macrophages.",
keywords = "Cyclooxygenase-2, Inducible nitric oxide synthase, Lipoteichoic acid, Nitric oxide, Nuclear factor-κB, Prostaglandin E, Protein kinase A, RAW 264.7 macrophages",
author = "Chang, {Yau Chong} and Li, {Pei Chih} and Chen, {Bing Chang} and Chang, {Ming Shyan} and Wang, {Jui Ling} and Chiu, {Wen Ta} and Lin, {Chien Huang}",
year = "2006",
month = "8",
doi = "10.1109/TCSI.2006.875167",
language = "English",
volume = "18",
pages = "1235--1243",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-κB pathways

AU - Chang, Yau Chong

AU - Li, Pei Chih

AU - Chen, Bing Chang

AU - Chang, Ming Shyan

AU - Wang, Jui Ling

AU - Chiu, Wen Ta

AU - Lin, Chien Huang

PY - 2006/8

Y1 - 2006/8

N2 - We recently reported that lipoteichoic acid (LTA), a cell wall component of the gram-positive bacterium Staphylococcus aureus, stimulated inducible nitric oxide synthase (iNOS) expression, nitric oxide (NO) release, and cyclooxygenase-2 (COX-2) expression in RAW 264.7 macrophages. This study was carried out to further investigate the roles of COX-2 and prostaglandin E2 (PGE2) in LTA-induced iNOS expression and NO release in RAW 264.7 macrophages. Treatment of RAW 264.7 macrophages with LTA caused a time-dependent increase in PGE2 release. LTA-induced iNOS expression and NO release were inhibited by a non-selective COX inhibitor (indomethacin), a selective COX-2 inhibitor (NS-398), an adenylyl cyclase (AC) inhibitor (dideoxyadenosine, DDA), and a protein kinase A (PKA) inhibitor (KT-5720). Furthermore, both PGE2 and the direct PKA activator, dibutyryl-cAMP, also induced iNOS expression in a concentration-dependent manner. Stimulation of RAW 264.7 macrophages with LTA, PGE2, and dibutyryl-cAMP all caused p38 MAPK activation in a time-dependent manner. LTA-mediated p38 MAPK activation was inhibited by indomethacin, NS-398, and SB 203580, but not by PD 98059. The PGE2-mediated p38 MAPK activation was inhibited by DDA, KT-5720, and SB 203580, but not by PD 98059. LTA caused time-dependent activation of the nuclear factor-κB (NF-κB)-specific DNA-protein complex formation. The LTA-induced increase in κB-luciferase activity was inhibited by indomethacin, NS-398, KT-5720, and a dominant negative mutant of p38 αMAPK (p38 αMAPK DN). These results suggest that LTA-induced iNOS expression and NO release involve COX-2-generated PGE2 production, and AC, PKA, p38 MAPK, and NF-κB activation in RAW 264.7 macrophages.

AB - We recently reported that lipoteichoic acid (LTA), a cell wall component of the gram-positive bacterium Staphylococcus aureus, stimulated inducible nitric oxide synthase (iNOS) expression, nitric oxide (NO) release, and cyclooxygenase-2 (COX-2) expression in RAW 264.7 macrophages. This study was carried out to further investigate the roles of COX-2 and prostaglandin E2 (PGE2) in LTA-induced iNOS expression and NO release in RAW 264.7 macrophages. Treatment of RAW 264.7 macrophages with LTA caused a time-dependent increase in PGE2 release. LTA-induced iNOS expression and NO release were inhibited by a non-selective COX inhibitor (indomethacin), a selective COX-2 inhibitor (NS-398), an adenylyl cyclase (AC) inhibitor (dideoxyadenosine, DDA), and a protein kinase A (PKA) inhibitor (KT-5720). Furthermore, both PGE2 and the direct PKA activator, dibutyryl-cAMP, also induced iNOS expression in a concentration-dependent manner. Stimulation of RAW 264.7 macrophages with LTA, PGE2, and dibutyryl-cAMP all caused p38 MAPK activation in a time-dependent manner. LTA-mediated p38 MAPK activation was inhibited by indomethacin, NS-398, and SB 203580, but not by PD 98059. The PGE2-mediated p38 MAPK activation was inhibited by DDA, KT-5720, and SB 203580, but not by PD 98059. LTA caused time-dependent activation of the nuclear factor-κB (NF-κB)-specific DNA-protein complex formation. The LTA-induced increase in κB-luciferase activity was inhibited by indomethacin, NS-398, KT-5720, and a dominant negative mutant of p38 αMAPK (p38 αMAPK DN). These results suggest that LTA-induced iNOS expression and NO release involve COX-2-generated PGE2 production, and AC, PKA, p38 MAPK, and NF-κB activation in RAW 264.7 macrophages.

KW - Cyclooxygenase-2

KW - Inducible nitric oxide synthase

KW - Lipoteichoic acid

KW - Nitric oxide

KW - Nuclear factor-κB

KW - Prostaglandin E

KW - Protein kinase A

KW - RAW 264.7 macrophages

UR - http://www.scopus.com/inward/record.url?scp=33646358491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646358491&partnerID=8YFLogxK

U2 - 10.1109/TCSI.2006.875167

DO - 10.1109/TCSI.2006.875167

M3 - Article

C2 - 16289764

AN - SCOPUS:33646358491

VL - 18

SP - 1235

EP - 1243

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 8

ER -